Effect of high-flow nasal cannula oxygen therapy on respiratory adverse events during anesthesia recovery period of pediatric adenotonsillectomy and adenoidectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054638

Enrollment

Unknown

Registered

2021-12-22

Start date

2021-12-22

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory adverse events during anesthesia recovery period

Interventions

Experimental group:Nasal High Flow Humidified Oxygenation Therapy

Control group:Routine extubation

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3 to 7 years; 2. ASA score III; 3. Elective surgery for tonsillectomy and (or) adenoidectomy under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Nasal obstruction; 2. Congenital heart disease or lung disease; 3. Anemia; 4. The acute phase of upper respiratory tract infection; 5. The patient or guardian refuses to participate in the study.

Design outcomes

Primary

Measure	Time frame
The incidence of respiratory adverse events;	—

Secondary

Measure	Time frame
Incidence and severity of hypoxemia;Cost and effect of response measures;Self-assessment of labor intensity by anesthesia nurses;	—

Countries

China

Contacts

Public ContactLi Wenxian

Eye & ENT Hospital, Fudan University

liwenxian@eentanesthesia.com+86 13917426838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026